Pfizer has a long history of innovation in healthcare and research, across the world and in New Zealand.
In 1961 Pfizer began operations in Auckland. Many of the diseases that significantly impacted the lives of Kiwis at that time can now be managed through medication because of the hard work and commitment of Pfizer people, and others working in the health sector.
Every day we work to ensure Kiwis can reliably access existing, new and innovative medicines and vaccines, that are being used to treat some of the most challenging conditions of our time.
Pfizer in New Zealand
Pfizer New Zealand established
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Launch of sustained-release drug ‘Eryc’ (enteric-coated pellets of erythromycin)
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Acquisition of G-Chem
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Discovery and launch of the world’s first patient-controlled analgesia (PCA) device
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Triple rollout of major new medicines: Zoloft®, Norvasc® and Zithromax®
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Acquisition of SmithKline Beecham’s animal health business
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Acquisition of Warner Lambert, gaining Lipitor®
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Acquisition of Pharmacia, gaining pain management medicine Celebrex®
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Acquisition of CSL Animal Health
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Sale of Pfizer Consumer Health
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Acquisition of Wyeth expands biopharmaceutical portfolio
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Sale of Pfizer Nutrition
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Spin off of Pfizer’s Animal Health unit, Zoetis
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Acquisition of Baxter’s vaccines portfolio
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Acquisition of Hospira, establishing New Zealand’s largest range of sterile injectable products
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Acquisition of Medivation boosting oncology expertise
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Spin off of Pfizer’s Consumer business into a Joint Venture with GSK
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Spin off of Pfizer’s Upjohn business to create a new company with Mylan called Viatris
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.